US20160302822A1 - Direction Reversing Vascular Treatment Device - Google Patents
Direction Reversing Vascular Treatment Device Download PDFInfo
- Publication number
- US20160302822A1 US20160302822A1 US15/194,083 US201615194083A US2016302822A1 US 20160302822 A1 US20160302822 A1 US 20160302822A1 US 201615194083 A US201615194083 A US 201615194083A US 2016302822 A1 US2016302822 A1 US 2016302822A1
- Authority
- US
- United States
- Prior art keywords
- intraluminal member
- drive system
- motor
- rotation
- motorized drive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12009—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
- A61B17/12013—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320758—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12181—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices
- A61B17/12186—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device formed by fluidized, gelatinous or cellular remodelable materials, e.g. embolic liquids, foams or extracellular matrices liquid materials adapted to be injected
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B2017/320733—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a flexible cutting or scraping element, e.g. with a whip-like distal filament member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320758—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven
- A61B2017/320766—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with a rotating cutting instrument, e.g. motor driven eccentric
Definitions
- This specification relates to the field of vascular treatment.
- Sclerotherapy can be used to treat blood vessels, blood vessel malformations, and similar problems in other body systems, such as the lymphatic system, and has been used in various forms for over 150 years. In its more modern form, sclerotherapy has been used since the 1960's, in Europe, for treating various vein conditions such as; varicose veins, reticular veins, spider veins of the leg, and also some fine facial veins.
- Sclerotherapy can be used to treat these conditions by instigating vascular fibrosis and obliteration in response to irreversible endothelial cellular destruction and exposure of the underlying subendothelial cell layer.
- This destruction is usually caused by the injection of a sclerosant into the vein.
- the injected sclerosant is too weak, there may be no endothelial injury at all.
- the sclerosant is a little stronger, the varicose vessel is damaged, but recanalization occurs and an incompetent pathway for retrograde blood flow persists.
- the varicose vessel endothelium is destroyed, but adjacent vessels that are not targeted for treatment may also be damaged by the sclerosant.
- the requirement for an ideal strength of the sclerosant is complicated by the constant flow of blood through the vein that is being treated. This flow simultaneously dilutes, and thereby weakens, the sclerosant, while also transporting the sclerosant to other parts of the vascular system.
- the apparatus can include, for example, an elongated intraluminal member shaped and dimensioned for passage through blood vessels of a subject.
- the intraluminal member can include, for example, a proximal end and a distal end.
- the apparatus can further include a motorized drive system coupled to the intraluminal member.
- the motorized drive system can, in some embodiments, reverse the direction of rotation of the intraluminal member.
- the motorized drive system can be, for example, a reversible motor, a kinematic chain, or a gearbox. In some embodiments of the apparatus, the motorized drive system can rotationally oscillate the intraluminal member. In some embodiments, the motorized drive system can oscillate the intraluminal member in a manner configured to inhibit entanglement of the intraluminal member with the vein, or can reverse the direction of rotation when a load threshold is reached or exceeded.
- Some embodiments relate to a method for vascular treatment.
- the method can include, for example, advancing an elongated intraluminal member from an access site and into the vein.
- the method may comprise rotating the intraluminal member or portion thereof in a first direction, and reversing the direction of rotation of the intraluminal member or portion thereof.
- the reversal of a direction of rotation occurs when a threshold load is met or exceeded.
- the rotation reversal can, for example, inhibit entanglement of the intraluminal member with the vein.
- a vascular treatment apparatus comprises an elongated intraluminal member shaped and dimensioned for passage through blood vessels of a subject, the intraluminal member including a proximal end and a distal end. At least a first motor is coupled to the intraluminal member to move the intraluminal member, a motor drive circuit is coupled to the motor; and a load sensor is coupled to the motor drive circuit. The motor drive circuit may stop or reverse direction of the motor in response to a sensed load.
- the apparatus and methods may be applied to permanently occluding veins.
- the intraluminal member may have a portion that can produce damage to the inner vein wall.
- the apparatus may further comprise a source of sclerosant and a fluid channel between the source of sclerosant and the distal end of the elongated intraluminal member.
- FIG. 1 shows an embodiment of an assembly of a vascular treatment device.
- FIG. 2A illustrates a longitudinal cross-sectional view of the embodiment illustrated in FIG. 1 .
- FIG. 2B illustrates the distal ends of the wire and sheath of FIG. 2A with the distal end of the wire within the sheath.
- FIG. 2C illustrates the distal ends of the wire and sheath of FIG. 2A with the distal end of the wire extending out from the end of the sheath.
- FIG. 3 shows a schematic view of a motion system for a vascular treatment device that incorporates a reversible motor.
- FIG. 4 shows a schematic view of a motion system for a vascular treatment device that incorporates an oscillating gear system.
- FIG. 5 shows a schematic view of a motion system for a vascular treatment device that incorporates a reversible motor with load sensing and additional control functions.
- FIG. 1 depicts a perspective view of one embodiment of exemplary components of a vascular treatment device 10 . These components can be configured to provide a range of functionalities to the vascular treatment device 10 .
- a vascular treatment device 10 can include features configured for stimulating vascular ablation, such as, for example, an intraluminal member 22 , a motorized drive system, including, for example, a motor, and/or control features and/or features configured for delivering liquid sclerosant.
- the intraluminal member comprises a wire surrounded by a sheath, and the wire is rotatable within the sheath. The space between the sheath and the wire can be used as a passage to inject sclerosant as the wire rotates, and the distal end of the wire forms a vein wall. disruptor.
- the vascular treatment device 10 of FIG. 1 is utilized by introducing the intraluminal member into a vein of a subject, where the vein is to be ablated in a treatment for varicose veins for example.
- the distal end of the wire is extended from the distal end of the sheath, and the wire is rotated or otherwise moved to damage the endothelium lining the inside surface of the vein.
- Sclerosant is also injected to the region of damage through the sheath that forms an outer portion of the intraluminal member 22 .
- the combination of endothelium damage plus the sclerosant provides a highly effective vascular ablation procedure with a minimum amount of injected sclerosant.
- a vascular treatment device can include a handle 12 and a cartridge 14 .
- each of the handle 12 and cartridge 14 can include features configured for stimulating vascular ablation and/or for delivering liquid sclerosant.
- the handle 12 and the cartridge 14 can comprise separate pieces.
- a handle 12 and a cartridge 14 can comprise an integrated component.
- a person of skill in the art will recognize that the present disclosure is not limited to a specific configuration of the handle 12 and cartridge 14 but broadly includes the range of functions and uses of a vascular therapy device.
- the cartridge 14 can be, for example, sized and shaped to engagingly connect to the handle 12 .
- this engaging connection can be achieved by fitting features of the handle 12 to features of the cartridge 14 .
- FIG. 2 depicts a side cross-section view of the vascular treatment device 10 of FIG. 1 .
- the vascular treatment device 10 depicted in FIG. 2 comprises the same features discussed in relation to FIG. 1 .
- the cartridge 14 may include a sheath 30 affixed to and extending from the cartridge 14 , a wire 32 , and a coupling 34 .
- the wire 32 can be, for example, fixed to the coupling 34 .
- the wire 32 can be affixed to the coupling 34 through a variety of techniques and methods.
- the wire 32 can be affixed to a range of features of a vascular treatment device 10 configured for driving the wire 32 .
- the wire 32 (and surrounding sheath) can comprise a variety of lengths.
- a wire 32 can have a length matching the needs of the procedure.
- a wire 32 can have a length, for example, of up to 10 cm, up to 25 cm, up to 75 cm, or up to 150 cm.
- the sheath 30 can be configured to define a lumen through which the wire 32 runs, and can be configured to allow independent motion of the wire within the sheath.
- the sheath 30 can have a variety of inner and outer diameters. In some embodiments, the sheath 30 can have an inner diameter ranging from approximately 0.022 inches to 0.048 inches. In some embodiments, the sheath 30 can have an outer diameter ranging from approximately 0.025 inches to 0.051 inches. In some embodiments, the outer diameter of the sheath 30 can be in the range that is, for example, consistent with the inner diameter of standard needles or vascular sheaths used for used for insertion of vascular catheters.
- the sheath 30 may also include external markings at regular intervals which may guide the user to monitor the insertion or removal speed of the intraluminal member 22 .
- a vascular treatment device 10 can be configured for use with injectant.
- the cartridge 14 can be configured for holding an injectant such as sclerosant in a syringe 36 attached to the cartridge 14 at a coupler 28 .
- Some embodiments of a vascular treatment device 10 and/or a cartridge 14 configured for use in connection with an injectant can be, for example, configured with valves and connectors to facilitate such use.
- a syringe 36 can, for example, connect to a stopcock 38 on a cartridge 14 .
- the stopcock 38 shown in FIG. 2 can be configured to allow the removal and/or attachment of a syringe to the vascular treatment device 10 during a procedure.
- a stopcock 38 can be configured to allow reloading of fluid and/or exchanging of containers to, for example, change the injectant or the concentration of the injectant.
- the stopcock 38 can be configured to provide additional functionality, such as, for example, mixing or aerating the injectant.
- the output of the coupler 28 is in fluid communication with the space between the sheath 30 and the wire 32 so that the injectant can be pushed along this space to the distal end of the wire and sheath where the injectant (e.g. sclerosant) exits the sheath when installed in the vein,
- the sheath 30 with the wire 32 inside may be introduced into the vein prior to coupling the cartridge 14 to the handle 12 .
- the wire 32 may be fully enclosed by the sheath 30 as shown in FIG. 2B .
- the cartridge 14 can be inserted into the handle 12 , and the coupler 34 can engage a mating coupler 40 in the handle.
- the coupler 34 in the cartridge which is attached to the wire 32 may be slidable within the cartridge 14 , so that when the coupler 34 in the cartridge is forced into engagement with the coupler 40 , the distal end of the wire 32 is pushed out of the sheath 30 , as shown in FIG. 2C .
- the coupler 40 in the handle 12 is attached to the shaft of a motor 42 in the handle that may rotate the coupler 40 , mated coupler 34 , and attached wire 32 to scrape and damage the inner wall of the vein.
- sclerosant may be forced down the sheath, to exit the sheath in the region near the distal end of the wire 32 , as shown by arrows 46 in FIG. 2C .
- Motor rotation may be controlled by a trigger 48 in the handle that depresses and releases a switch 50 to start and stop motor rotation.
- the handle 12 may further include a power source for the motor such as battery 52 .
- Embodiments of vascular treatment devices such as illustrated in FIGS. 1 through 2C are further described in U.S. Pat. Nos. 7,862,575 and 7,967,834 which are incorporated herein by reference in their entireties.
- FIG. 3 illustrates one embodiment of a wire 32 drive system that helps resolve these problems.
- a motor 50 used to drive the wire 32 is a reversible motor.
- the motor 50 is controlled by a motor control and driver circuit 52 that is configured to periodically change the direction of rotation of the wire 32 .
- Such a change in direction can be performed at defined time intervals such as one a second, ten times a second, etc., or the change in direction can be performed after a set number of rotations such as every five rotations, or with every rotation, or with fractions of a rotation if desired. Random or pseudo-random timing of rotation changes is also possible.
- a variety of rotational oscillation motions can be programmed or hard wired into the motor control and driver circuit 52 .
- Such motors and motor control circuits are well known and commercially available, and can be used in place of the motor 42 and single direction rotation of FIG. 2 . With these direction rotations, entanglement with the vein is less likely, and if it does occur, the next direction reversal is likely to free the wire from the vein.
- FIG. 4 depicts a motorized drive system comprising a trigger 48 , a motor driver circuit 54 , a motor 56 , and a kinematic chain 58 connecting the motor 56 to the coupler 40 .
- the kinematic chain 58 can comprise, for example, an assemblage of links and joints interconnected so as to provide a desired output in response to desired input.
- the kinematic chain 58 can comprise one or several gears, one or several rigid linked members, one or several flexible linked members, or any other desired feature.
- the kinematic chain 58 can be configured to translate a single direction motor 56 output into rotational oscillation of the wire 32 .
- FIG. 4 depicts one specific kinematic chain 58 comprising a first wheel 60 , a link 62 , and a second wheel 64 .
- the motor 56 can rotate the first wheel 60 about the axis of the motor driven shaft.
- a first end of the link 62 can be rotationally connected to a portion of the first wheel 60
- a second end of the link 62 can be rotationally and slidingly connected with a portion of the second wheel 64 .
- the combination of the rotational connection of the first end of the link 62 to the first wheel 60 , and the rotational and sliding connection of the second end of the link 62 to the second wheel 64 can allow conversion of the single direction rotational input of the driven shaft of the motor to rotationally oscillating output of the motorized drive system output,
- one specific kinematic chain 58 is described herein, a person of skill in the art will recognize that a variety of kinematic chains can be used in connection with the motorized drive system to achieve the desired movement of the wire 32 .
- the motorized drive system of FIG. 4 utilizes a simpler and less expensive motor and motor drive circuit compared to the system of FIG. 3 , with the addition of the mechanical components of the kinematic chain 58 .
- FIG. 5 depicts a motorized drive system comprising a trigger 48 , a motor control and driver circuit 72 , and a reversible motor 70 .
- FIG. 5 depicts a load sensor 76 that may be incorporated into the motor control and driver circuit 72 .
- the load sensor 76 can be configured to detect the motor load based on inputs from an output current sensor 74 that senses the current being used to drive the motor and/or other sensor signals such as speed and torque signals that may be routed to the motor control and drive circuit 72 from sensors integral to the motor 70 .
- the load sensor may determine that the current to the motor has exceeded a threshold, that the torque output has exceeded a threshold, or that the speed of rotation has slowed below a threshold.
- load sensor, 76 current sensor 74 or other motor parameter sensors can be incorporated into the motor 70 , the motor control and driver circuit 72 , be standalone components, or have portions thereof distributed in any of these or other locations.
- the load sensor 76 can comprise software, hardware, or a combination of hardware and software.
- the motor control and driver circuit 72 can be configured to control the motor based in part on signals generated by the motor load sensor 76 .
- the motor control and driver circuit 72 may speed up the rotation rate of the motor 70 , slow down the rotation rate of the motor 70 , or reverse the direction of rotation of the motor 70 in response to signals generated by the motor load sensor 76 .
- the motor control and driver circuit 72 can be configured to reverse the direction of rotation of the motor 72 when the motor load sensor 76 detects a motor load which meets or exceeds a load threshold.
- this load threshold can, for example, correspond to a condition with the treated vessel, such as, for example, entanglement of the wire 32 in vein tissue, over penetration of the wire 32 into vein tissue, or other conditions.
- the reversing of the direction of rotation of the motor 70 , and thereby reversing the direction of rotation of the wire 32 can minimize the severity and duration of, and/or prevent entanglement of the wire 32 with the vein.
- the motor control and driver circuit 72 is user programmable with a variety of motor control options.
- the user may, for example, be able to select a rotation speed, a desired torque value or torque limit during the procedure, the direction of rotation, and whether and how quickly the wire should oscillate back and forth with reversing rotations or rotate in one direction only.
- the motorized drive system can, for example, be programmable to rotate the wire 32 at any rate between approximately 500 to 5,000 rpm, and reverse direction at any rate between every half rotation to every 500 rotations.
- the device could include switches or a keypad for such programmable control, or may have an input/output port for interfacing to a computer for download of configuration choices.
- the behavior of the motor control and driver circuit 72 in response to sensor inputs related to load, speed, etc. could also be programmable, or may be fixed at manufacture.
Abstract
Description
- This application claims the benefit of U.S. Provisional Application No. 61/413,895, filed on Nov. 15, 2010, the disclosure of which is hereby incorporated by reference in its entirety.
- 1. Field of the Invention
- This specification relates to the field of vascular treatment.
- 2. Description of the Related Art
- Sclerotherapy can be used to treat blood vessels, blood vessel malformations, and similar problems in other body systems, such as the lymphatic system, and has been used in various forms for over 150 years. In its more modern form, sclerotherapy has been used since the 1960's, in Europe, for treating various vein conditions such as; varicose veins, reticular veins, spider veins of the leg, and also some fine facial veins.
- Sclerotherapy can be used to treat these conditions by instigating vascular fibrosis and obliteration in response to irreversible endothelial cellular destruction and exposure of the underlying subendothelial cell layer. This destruction is usually caused by the injection of a sclerosant into the vein. However, if the injected sclerosant is too weak, there may be no endothelial injury at all. If the sclerosant is a little stronger, the varicose vessel is damaged, but recanalization occurs and an incompetent pathway for retrograde blood flow persists. Finally, if the injected sclerosant is too strong, the varicose vessel endothelium is destroyed, but adjacent vessels that are not targeted for treatment may also be damaged by the sclerosant.
- The requirement for an ideal strength of the sclerosant is complicated by the constant flow of blood through the vein that is being treated. This flow simultaneously dilutes, and thereby weakens, the sclerosant, while also transporting the sclerosant to other parts of the vascular system.
- Thus, improved methods and devices for treating the vascular system are desired.
- Some embodiments relate to a vascular treatment apparatus. The apparatus can include, for example, an elongated intraluminal member shaped and dimensioned for passage through blood vessels of a subject. The intraluminal member can include, for example, a proximal end and a distal end. The apparatus can further include a motorized drive system coupled to the intraluminal member. The motorized drive system can, in some embodiments, reverse the direction of rotation of the intraluminal member.
- In some embodiments of the apparatus, the motorized drive system can be, for example, a reversible motor, a kinematic chain, or a gearbox. In some embodiments of the apparatus, the motorized drive system can rotationally oscillate the intraluminal member. In some embodiments, the motorized drive system can oscillate the intraluminal member in a manner configured to inhibit entanglement of the intraluminal member with the vein, or can reverse the direction of rotation when a load threshold is reached or exceeded.
- Some embodiments relate to a method for vascular treatment. The method can include, for example, advancing an elongated intraluminal member from an access site and into the vein. The method may comprise rotating the intraluminal member or portion thereof in a first direction, and reversing the direction of rotation of the intraluminal member or portion thereof. In some embodiments of the method, the reversal of a direction of rotation occurs when a threshold load is met or exceeded. The rotation reversal can, for example, inhibit entanglement of the intraluminal member with the vein.
- In another embodiment, a vascular treatment apparatus comprises an elongated intraluminal member shaped and dimensioned for passage through blood vessels of a subject, the intraluminal member including a proximal end and a distal end. At least a first motor is coupled to the intraluminal member to move the intraluminal member, a motor drive circuit is coupled to the motor; and a load sensor is coupled to the motor drive circuit. The motor drive circuit may stop or reverse direction of the motor in response to a sensed load.
- In one specific application, the apparatus and methods may be applied to permanently occluding veins. In these embodiments, the intraluminal member may have a portion that can produce damage to the inner vein wall. The apparatus may further comprise a source of sclerosant and a fluid channel between the source of sclerosant and the distal end of the elongated intraluminal member.
- The foregoing is a summary and thus contains, by necessity, simplifications, generalization, and omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is not intended to be in any way limiting. Other aspects, features, and advantages of the devices and/or processes and/or other subject matter described herein will become apparent in the teachings set forth herein. The summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
-
FIG. 1 shows an embodiment of an assembly of a vascular treatment device. -
FIG. 2A illustrates a longitudinal cross-sectional view of the embodiment illustrated inFIG. 1 . -
FIG. 2B illustrates the distal ends of the wire and sheath ofFIG. 2A with the distal end of the wire within the sheath. -
FIG. 2C illustrates the distal ends of the wire and sheath ofFIG. 2A with the distal end of the wire extending out from the end of the sheath. -
FIG. 3 shows a schematic view of a motion system for a vascular treatment device that incorporates a reversible motor. -
FIG. 4 shows a schematic view of a motion system for a vascular treatment device that incorporates an oscillating gear system. -
FIG. 5 shows a schematic view of a motion system for a vascular treatment device that incorporates a reversible motor with load sensing and additional control functions. - The following description and examples illustrate preferred embodiments of the present invention in detail. Those of skill in the art will recognize that there are numerous variations and modifications of this invention that are encompassed by its scope. Accordingly, the description of a preferred embodiment should not be deemed to limit the scope of the present invention. In this description, reference is made to the drawings wherein like parts are designated with like numerals throughout.
-
FIG. 1 depicts a perspective view of one embodiment of exemplary components of avascular treatment device 10. These components can be configured to provide a range of functionalities to thevascular treatment device 10. In some embodiments, avascular treatment device 10 can include features configured for stimulating vascular ablation, such as, for example, anintraluminal member 22, a motorized drive system, including, for example, a motor, and/or control features and/or features configured for delivering liquid sclerosant. In some embodiments described further below, the intraluminal member comprises a wire surrounded by a sheath, and the wire is rotatable within the sheath. The space between the sheath and the wire can be used as a passage to inject sclerosant as the wire rotates, and the distal end of the wire forms a vein wall. disruptor. - In general, the
vascular treatment device 10 ofFIG. 1 is utilized by introducing the intraluminal member into a vein of a subject, where the vein is to be ablated in a treatment for varicose veins for example. The distal end of the wire is extended from the distal end of the sheath, and the wire is rotated or otherwise moved to damage the endothelium lining the inside surface of the vein. Sclerosant is also injected to the region of damage through the sheath that forms an outer portion of theintraluminal member 22. The combination of endothelium damage plus the sclerosant provides a highly effective vascular ablation procedure with a minimum amount of injected sclerosant. - As depicted in
FIG. 1 , a vascular treatment device can include ahandle 12 and acartridge 14. As explained below in greater detail, each of thehandle 12 andcartridge 14 can include features configured for stimulating vascular ablation and/or for delivering liquid sclerosant. In one embodiment, and as depicted inFIG. 1 , thehandle 12 and thecartridge 14 can comprise separate pieces. In another embodiment, ahandle 12 and acartridge 14 can comprise an integrated component. A person of skill in the art will recognize that the present disclosure is not limited to a specific configuration of thehandle 12 andcartridge 14 but broadly includes the range of functions and uses of a vascular therapy device. - As further depicted in
FIG. 1 , thecartridge 14 can be, for example, sized and shaped to engagingly connect to thehandle 12. In one embodiment, and as shown inFIG. 1 , this engaging connection can be achieved by fitting features of thehandle 12 to features of thecartridge 14. -
FIG. 2 depicts a side cross-section view of thevascular treatment device 10 ofFIG. 1 . Thevascular treatment device 10 depicted inFIG. 2 comprises the same features discussed in relation toFIG. 1 . Referring now to bothFIGS. 1 and 2 , thecartridge 14 may include asheath 30 affixed to and extending from thecartridge 14, awire 32, and acoupling 34. Thewire 32 can be, for example, fixed to thecoupling 34. A person of skill in the art will recognize that thewire 32 can be affixed to thecoupling 34 through a variety of techniques and methods. A person of skill in the art will further recognize that thewire 32 can be affixed to a range of features of avascular treatment device 10 configured for driving thewire 32. - The wire 32 (and surrounding sheath) can comprise a variety of lengths. In some embodiments, a
wire 32 can have a length matching the needs of the procedure. In some embodiments, awire 32 can have a length, for example, of up to 10 cm, up to 25 cm, up to 75 cm, or up to 150 cm. - The
sheath 30 can be configured to define a lumen through which thewire 32 runs, and can be configured to allow independent motion of the wire within the sheath. Thesheath 30 can have a variety of inner and outer diameters. In some embodiments, thesheath 30 can have an inner diameter ranging from approximately 0.022 inches to 0.048 inches. In some embodiments, thesheath 30 can have an outer diameter ranging from approximately 0.025 inches to 0.051 inches. In some embodiments, the outer diameter of thesheath 30 can be in the range that is, for example, consistent with the inner diameter of standard needles or vascular sheaths used for used for insertion of vascular catheters. - The
sheath 30 may also include external markings at regular intervals which may guide the user to monitor the insertion or removal speed of theintraluminal member 22. - Some embodiments of a
vascular treatment device 10 can be configured for use with injectant. In some embodiments, thecartridge 14 can be configured for holding an injectant such as sclerosant in asyringe 36 attached to thecartridge 14 at acoupler 28. Some embodiments of avascular treatment device 10 and/or acartridge 14 configured for use in connection with an injectant can be, for example, configured with valves and connectors to facilitate such use. In some embodiments, asyringe 36 can, for example, connect to a stopcock 38 on acartridge 14. The stopcock 38 shown inFIG. 2 can be configured to allow the removal and/or attachment of a syringe to thevascular treatment device 10 during a procedure. In some embodiments, a stopcock 38 can be configured to allow reloading of fluid and/or exchanging of containers to, for example, change the injectant or the concentration of the injectant. In some embodiments, the stopcock 38 can be configured to provide additional functionality, such as, for example, mixing or aerating the injectant. The output of thecoupler 28 is in fluid communication with the space between thesheath 30 and thewire 32 so that the injectant can be pushed along this space to the distal end of the wire and sheath where the injectant (e.g. sclerosant) exits the sheath when installed in the vein, - In use, the
sheath 30 with thewire 32 inside may be introduced into the vein prior to coupling thecartridge 14 to thehandle 12. At this time, thewire 32 may be fully enclosed by thesheath 30 as shown inFIG. 2B . After introduction, thecartridge 14 can be inserted into thehandle 12, and thecoupler 34 can engage amating coupler 40 in the handle. Thecoupler 34 in the cartridge which is attached to thewire 32 may be slidable within thecartridge 14, so that when thecoupler 34 in the cartridge is forced into engagement with thecoupler 40, the distal end of thewire 32 is pushed out of thesheath 30, as shown inFIG. 2C . This exposes a portion of thewire 32 that is configured to damage the endothelium on the inner surface of the vein. Thecoupler 40 in thehandle 12 is attached to the shaft of amotor 42 in the handle that may rotate thecoupler 40, matedcoupler 34, and attachedwire 32 to scrape and damage the inner wall of the vein. During this process, sclerosant may be forced down the sheath, to exit the sheath in the region near the distal end of thewire 32, as shown byarrows 46 inFIG. 2C . - Motor rotation may be controlled by a
trigger 48 in the handle that depresses and releases aswitch 50 to start and stop motor rotation. Thehandle 12 may further include a power source for the motor such asbattery 52. Embodiments of vascular treatment devices such as illustrated inFIGS. 1 through 2C are further described in U.S. Pat. Nos. 7,862,575 and 7,967,834 which are incorporated herein by reference in their entireties. - Although vascular ablation treatments using the above described vascular treatment device have shown dramatic improvement over prior vascular ablation methods, it has been found that the drive system illustrated in
FIG. 2A is sometimes not optimal. For example, the distal end of thewire 32 can sometimes catch on the inner vein wall, twisting the vein and entangling the wire and the vein. When this occurs, the operator of the device may need to stop the procedure to release the wire from the vein. This issue may be caused by insufficient control or variation of motor motion during the procedure, a problem that is addressed by the embodiments described below with respect toFIGS. 3, 4, and 5 . -
FIG. 3 illustrates one embodiment of awire 32 drive system that helps resolve these problems. InFIGS. 3, 4, and 5 , many components of thecartridge 14 and handle 12 are omitted for clarity, focusing only on the drive system forwire 32.Couplers FIG. 3 , amotor 50 used to drive thewire 32 is a reversible motor. Themotor 50 is controlled by a motor control anddriver circuit 52 that is configured to periodically change the direction of rotation of thewire 32. Such a change in direction can be performed at defined time intervals such as one a second, ten times a second, etc., or the change in direction can be performed after a set number of rotations such as every five rotations, or with every rotation, or with fractions of a rotation if desired. Random or pseudo-random timing of rotation changes is also possible. Thus, a variety of rotational oscillation motions can be programmed or hard wired into the motor control anddriver circuit 52. Such motors and motor control circuits are well known and commercially available, and can be used in place of themotor 42 and single direction rotation ofFIG. 2 . With these direction rotations, entanglement with the vein is less likely, and if it does occur, the next direction reversal is likely to free the wire from the vein. -
FIG. 4 depicts a motorized drive system comprising atrigger 48, amotor driver circuit 54, amotor 56, and akinematic chain 58 connecting themotor 56 to thecoupler 40. Thekinematic chain 58 can comprise, for example, an assemblage of links and joints interconnected so as to provide a desired output in response to desired input. In some embodiments, thekinematic chain 58 can comprise one or several gears, one or several rigid linked members, one or several flexible linked members, or any other desired feature. In some embodiments, thekinematic chain 58 can be configured to translate asingle direction motor 56 output into rotational oscillation of thewire 32. -
FIG. 4 depicts onespecific kinematic chain 58 comprising afirst wheel 60, alink 62, and asecond wheel 64. In some embodiments, themotor 56 can rotate thefirst wheel 60 about the axis of the motor driven shaft. A first end of thelink 62 can be rotationally connected to a portion of thefirst wheel 60, and a second end of thelink 62 can be rotationally and slidingly connected with a portion of thesecond wheel 64. The combination of the rotational connection of the first end of thelink 62 to thefirst wheel 60, and the rotational and sliding connection of the second end of thelink 62 to thesecond wheel 64 can allow conversion of the single direction rotational input of the driven shaft of the motor to rotationally oscillating output of the motorized drive system output, Although onespecific kinematic chain 58 is described herein, a person of skill in the art will recognize that a variety of kinematic chains can be used in connection with the motorized drive system to achieve the desired movement of thewire 32. The motorized drive system ofFIG. 4 utilizes a simpler and less expensive motor and motor drive circuit compared to the system ofFIG. 3 , with the addition of the mechanical components of thekinematic chain 58. -
FIG. 5 depicts a motorized drive system comprising atrigger 48, a motor control anddriver circuit 72, and areversible motor 70. In addition to these features,FIG. 5 depicts aload sensor 76 that may be incorporated into the motor control anddriver circuit 72. Theload sensor 76 can be configured to detect the motor load based on inputs from an outputcurrent sensor 74 that senses the current being used to drive the motor and/or other sensor signals such as speed and torque signals that may be routed to the motor control and drivecircuit 72 from sensors integral to themotor 70. For example, the load sensor may determine that the current to the motor has exceeded a threshold, that the torque output has exceeded a threshold, or that the speed of rotation has slowed below a threshold. It will be appreciated that the load sensor, 76,current sensor 74 or other motor parameter sensors can be incorporated into themotor 70, the motor control anddriver circuit 72, be standalone components, or have portions thereof distributed in any of these or other locations. Theload sensor 76 can comprise software, hardware, or a combination of hardware and software. - The motor control and
driver circuit 72 can be configured to control the motor based in part on signals generated by themotor load sensor 76. In some embodiments, the motor control anddriver circuit 72 may speed up the rotation rate of themotor 70, slow down the rotation rate of themotor 70, or reverse the direction of rotation of themotor 70 in response to signals generated by themotor load sensor 76. In one embodiment, the motor control anddriver circuit 72 can be configured to reverse the direction of rotation of themotor 72 when themotor load sensor 76 detects a motor load which meets or exceeds a load threshold. In some embodiments, this load threshold can, for example, correspond to a condition with the treated vessel, such as, for example, entanglement of thewire 32 in vein tissue, over penetration of thewire 32 into vein tissue, or other conditions. Advantageously, the reversing of the direction of rotation of themotor 70, and thereby reversing the direction of rotation of thewire 32 can minimize the severity and duration of, and/or prevent entanglement of thewire 32 with the vein. - In some embodiments, the motor control and
driver circuit 72 is user programmable with a variety of motor control options. The user may, for example, be able to select a rotation speed, a desired torque value or torque limit during the procedure, the direction of rotation, and whether and how quickly the wire should oscillate back and forth with reversing rotations or rotate in one direction only. The motorized drive system can, for example, be programmable to rotate thewire 32 at any rate between approximately 500 to 5,000 rpm, and reverse direction at any rate between every half rotation to every 500 rotations. - The device could include switches or a keypad for such programmable control, or may have an input/output port for interfacing to a computer for download of configuration choices. The behavior of the motor control and
driver circuit 72 in response to sensor inputs related to load, speed, etc. could also be programmable, or may be fixed at manufacture. - The foregoing description details certain embodiments of the devices and methods disclosed herein. It will be appreciated, however, that no matter how detailed the foregoing appears in text, the devices and methods can be practiced in many ways. As is also stated above, it should be noted that the use of particular terminology when describing certain features or aspects of the invention should not be taken to imply that the terminology is being re-defined herein to be restricted to including any specific characteristics of the features or aspects of the technology with which that terminology is associated. Furthermore, although the above description has focused on the application of the principles discussed to vein ablation procedures, the features set forth above could be applied to a variety of vascular treatments.
- It will be appreciated by those skilled in the art that various modifications and changes may be made without departing from the scope of the described technology. Such modifications and changes are intended to fall within the scope of the embodiments. It will also be appreciated by those of skill in the art that parts included in one embodiment are interchangeable with other embodiments; one or more parts from a depicted embodiment can be included with other depicted embodiments in any combination. For example, any of the various components described herein and/or depicted in the Figures may be combined, interchanged or excluded from other embodiments.
- With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity
- It will be understood by those within the art that, in general, terms used herein are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” Should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). it will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
- All references cited herein are incorporated herein by reference in their entirety. To the extent publications and patents or patent applications incorporated by reference contradict the disclosure contained in the specification, the specification is intended to supersede and/or take precedence over any such contradictory material.
- The term “comprising” as used herein is synonymous with “including,” “containing,” or “characterized by,” and is inclusive or open-ended and does not exclude additional, unrecited elements or method steps.
Claims (29)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/194,083 US20160302822A1 (en) | 2010-11-15 | 2016-06-27 | Direction Reversing Vascular Treatment Device |
US16/730,824 US20200129180A1 (en) | 2010-11-15 | 2019-12-30 | Direction reversing vascular treatment device |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41389510P | 2010-11-15 | 2010-11-15 | |
US13/295,495 US9375216B2 (en) | 2010-11-15 | 2011-11-14 | Direction reversing vascular treatment device |
US15/194,083 US20160302822A1 (en) | 2010-11-15 | 2016-06-27 | Direction Reversing Vascular Treatment Device |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/295,495 Division US9375216B2 (en) | 2010-11-15 | 2011-11-14 | Direction reversing vascular treatment device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/730,824 Continuation US20200129180A1 (en) | 2010-11-15 | 2019-12-30 | Direction reversing vascular treatment device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160302822A1 true US20160302822A1 (en) | 2016-10-20 |
Family
ID=46065039
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/194,253 Active US9585667B2 (en) | 2010-11-15 | 2011-07-29 | Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein |
US13/295,495 Active US9375216B2 (en) | 2010-11-15 | 2011-11-14 | Direction reversing vascular treatment device |
US13/295,518 Active US8696645B2 (en) | 2010-11-15 | 2011-11-14 | Vascular treatment devices and methods |
US14/218,527 Active 2032-04-24 US11241250B2 (en) | 2010-11-15 | 2014-03-18 | Vascular treatment devices and methods |
US15/194,083 Abandoned US20160302822A1 (en) | 2010-11-15 | 2016-06-27 | Direction Reversing Vascular Treatment Device |
US16/730,824 Abandoned US20200129180A1 (en) | 2010-11-15 | 2019-12-30 | Direction reversing vascular treatment device |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/194,253 Active US9585667B2 (en) | 2010-11-15 | 2011-07-29 | Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein |
US13/295,495 Active US9375216B2 (en) | 2010-11-15 | 2011-11-14 | Direction reversing vascular treatment device |
US13/295,518 Active US8696645B2 (en) | 2010-11-15 | 2011-11-14 | Vascular treatment devices and methods |
US14/218,527 Active 2032-04-24 US11241250B2 (en) | 2010-11-15 | 2014-03-18 | Vascular treatment devices and methods |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/730,824 Abandoned US20200129180A1 (en) | 2010-11-15 | 2019-12-30 | Direction reversing vascular treatment device |
Country Status (6)
Country | Link |
---|---|
US (6) | US9585667B2 (en) |
EP (5) | EP3378509B1 (en) |
JP (6) | JP6068355B2 (en) |
AU (7) | AU2011328998A1 (en) |
CA (3) | CA2817545C (en) |
WO (3) | WO2012068162A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020077280A1 (en) * | 2018-10-12 | 2020-04-16 | Merit Medical Systems, Inc. | Vascular treatment apparatus with remote operating module |
IT201900001223A1 (en) | 2019-01-28 | 2020-07-28 | I Vasc Srl | Catheter handpiece, catheter and method |
US11696793B2 (en) | 2021-03-19 | 2023-07-11 | Crossfire Medical Inc | Vascular ablation |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8430837B2 (en) | 2007-02-05 | 2013-04-30 | Boston Scientific Scimed, Inc. | Thrombectomy apparatus and method |
US9510854B2 (en) | 2008-10-13 | 2016-12-06 | Boston Scientific Scimed, Inc. | Thrombectomy catheter with control box having pressure/vacuum valve for synchronous aspiration and fluid irrigation |
US9585667B2 (en) | 2010-11-15 | 2017-03-07 | Vascular Insights Llc | Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein |
BR112013021463A2 (en) | 2011-02-24 | 2016-11-01 | Eximo Medical Ltd | tissue resection hybrid catheter |
JP6073493B2 (en) * | 2012-11-08 | 2017-02-01 | コヴィディエン リミテッド パートナーシップ | Tissue removal catheter including motion control mechanism |
US9180040B2 (en) | 2013-10-18 | 2015-11-10 | Contramed, Llc | Intrauterine device with retrieval thread |
US10271869B2 (en) | 2014-03-01 | 2019-04-30 | Rex Medical, L.P. | Atherectomy device |
US9248221B2 (en) | 2014-04-08 | 2016-02-02 | Incuvate, Llc | Aspiration monitoring system and method |
US9433427B2 (en) | 2014-04-08 | 2016-09-06 | Incuvate, Llc | Systems and methods for management of thrombosis |
US9883877B2 (en) | 2014-05-19 | 2018-02-06 | Walk Vascular, Llc | Systems and methods for removal of blood and thrombotic material |
US10702300B2 (en) * | 2014-07-18 | 2020-07-07 | Cardiovascular Systems, Inc. | Methods, devices and systems for slow rotation of drive shaft driven atherectomy systems |
US20160030023A1 (en) * | 2014-07-31 | 2016-02-04 | Terumo Kabushiki Kaisha | Method for treating varicose veins and intraluminal device used in such method |
US10463389B2 (en) | 2014-12-27 | 2019-11-05 | Rex Medical, L.P. | Atherectomy device |
US10433868B2 (en) | 2014-12-27 | 2019-10-08 | Rex Medical, L.P. | Artherectomy device |
US10702292B2 (en) | 2015-08-28 | 2020-07-07 | Incuvate, Llc | Aspiration monitoring system and method |
US10561440B2 (en) | 2015-09-03 | 2020-02-18 | Vesatek, Llc | Systems and methods for manipulating medical devices |
US11253292B2 (en) | 2015-09-13 | 2022-02-22 | Rex Medical, L.P. | Atherectomy device |
US20170100142A1 (en) | 2015-10-09 | 2017-04-13 | Incuvate, Llc | Systems and methods for management of thrombosis |
US10226263B2 (en) | 2015-12-23 | 2019-03-12 | Incuvate, Llc | Aspiration monitoring system and method |
US10307175B2 (en) | 2016-03-26 | 2019-06-04 | Rex Medical, L.P | Atherectomy device |
US10492805B2 (en) | 2016-04-06 | 2019-12-03 | Walk Vascular, Llc | Systems and methods for thrombolysis and delivery of an agent |
CN109414292A (en) | 2016-05-05 | 2019-03-01 | 爱克斯莫医疗有限公司 | Device and method for cutting off and/or melting unwanted tissue |
USD802769S1 (en) | 2016-05-16 | 2017-11-14 | Teleflex Medical Incorporated | Thrombectomy handle assembly |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
CN110573099B (en) | 2017-05-03 | 2023-01-03 | 美敦力瓦斯科尔勒公司 | Tissue removal catheter |
WO2019069739A1 (en) * | 2017-10-04 | 2019-04-11 | テルモ株式会社 | Medical device, method for controlling rotation of medical device, and rotation control equipment |
WO2019118522A1 (en) * | 2017-12-12 | 2019-06-20 | Boston Scientific Scimed, Inc. | Rotational medical device |
US11678905B2 (en) | 2018-07-19 | 2023-06-20 | Walk Vascular, Llc | Systems and methods for removal of blood and thrombotic material |
US11357534B2 (en) | 2018-11-16 | 2022-06-14 | Medtronic Vascular, Inc. | Catheter |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
KR20220060550A (en) | 2019-09-10 | 2022-05-11 | 바드 액세스 시스템즈, 인크. | RAPIDLY INSERTED CENTRAL CATHETER AND METHODS THEREOF |
KR20220070233A (en) | 2019-09-24 | 2022-05-30 | 바드 액세스 시스템즈, 인크. | AN INTEGRATED ACUTE CENTRAL VENOUS CATHETER AND PERIPHERALLY INSERTED VENOUS CATHETER |
US11826526B2 (en) | 2020-01-23 | 2023-11-28 | Bard Access Systems, Inc. | Splitable catheter docking station system and method |
GB202005780D0 (en) * | 2020-04-21 | 2020-06-03 | Whiteley Clinic | Vein Ablation |
KR20230007403A (en) | 2020-04-23 | 2023-01-12 | 바드 액세스 시스템즈, 인크. | RAPIDLY INSERTABLE CENTRAL CATHETERS INCLUDING CATHETER ASSEMBLIES |
CA3181532A1 (en) | 2020-05-21 | 2021-11-25 | Bard Access Systems, Inc. | Rapidly insertable central catheters including catheter assemblies |
US11911581B1 (en) | 2022-11-04 | 2024-02-27 | Controlled Delivery Systems, Inc. | Catheters and related methods for the aspiration controlled delivery of closure agents |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876109A (en) * | 1987-04-13 | 1989-10-24 | Cardiac Pacemakers, Inc. | Soluble covering for cardiac pacing electrode |
US6482215B1 (en) * | 1999-02-02 | 2002-11-19 | Samuel Shiber | Adjustable vessel cleaner and method |
US20040147934A1 (en) * | 2002-10-18 | 2004-07-29 | Kiester P. Douglas | Oscillating, steerable, surgical burring tool and method of using the same |
US20050055040A1 (en) * | 2003-05-21 | 2005-03-10 | Tal Michael G. | Vascular ablation apparatus and method |
US20070239140A1 (en) * | 2006-03-22 | 2007-10-11 | Revascular Therapeutics Inc. | Controller system for crossing vascular occlusions |
US20080140101A1 (en) * | 2006-12-07 | 2008-06-12 | Revascular Therapeutic, Inc. | Apparatus for crossing occlusions or stenoses |
US20100125276A1 (en) * | 2008-11-14 | 2010-05-20 | Revascular Therapeutics, Inc. | Method and system for reversibly controlled drilling of luminal occlusions |
Family Cites Families (172)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1740174A (en) * | 1928-09-10 | 1929-12-17 | Hevern Earl Ramsey | Embalmer's trocar |
US2212477A (en) * | 1939-06-19 | 1940-08-20 | Herman J Mayer | Injection needle |
US3029560A (en) | 1954-12-06 | 1962-04-17 | John B Benson | Building clip |
US3405712A (en) * | 1966-02-07 | 1968-10-15 | Richard L. Pierick | Desiccative syringe |
US3631847A (en) * | 1966-03-04 | 1972-01-04 | James C Hobbs | Method and apparatus for injecting fluid into the vascular system |
US3530492A (en) * | 1967-12-05 | 1970-09-22 | Jack R Ferber | Method and apparatus for administering hypodermic injections |
US3633566A (en) * | 1969-05-15 | 1972-01-11 | Systematics | Blood collecting method and device |
US3788326A (en) * | 1970-07-29 | 1974-01-29 | H Jacobs | Distally perforated catheter for use in ventilating system |
US4278085A (en) * | 1979-12-13 | 1981-07-14 | Baxter Travenol Laboratories, Inc. | Method and apparatus for metered infusion of fluids |
US4403611A (en) * | 1980-07-17 | 1983-09-13 | Babbitt Gerald J | Sinus evacuator apparatus |
US4586921A (en) * | 1983-08-17 | 1986-05-06 | Daniel Berson | Method of applying a local anesthetic agent to a wound |
US4577514A (en) * | 1984-04-09 | 1986-03-25 | Vanderbilt University | Method and apparatus for sampling liquid phase components from a liquid-semisolid fluid |
US4790812A (en) * | 1985-11-15 | 1988-12-13 | Hawkins Jr Irvin F | Apparatus and method for removing a target object from a body passsageway |
US4728319A (en) | 1986-03-20 | 1988-03-01 | Helmut Masch | Intravascular catheter |
US4791937A (en) * | 1986-08-19 | 1988-12-20 | Ko Pen Wang | Transendoscopic needle |
US5217478A (en) | 1987-02-18 | 1993-06-08 | Linvatec Corporation | Arthroscopic surgical instrument drive system |
US4936845A (en) * | 1987-03-17 | 1990-06-26 | Cordis Corporation | Catheter system having distal tip for opening obstructions |
US5116350B1 (en) * | 1987-03-17 | 1997-06-17 | Cordis Corp | Catheter system having distal tip for opening obstructions |
US4867156A (en) | 1987-06-25 | 1989-09-19 | Stack Richard S | Percutaneous axial atheroectomy catheter assembly and method of using the same |
US4857046A (en) * | 1987-10-21 | 1989-08-15 | Cordis Corporation | Drive catheter having helical pump drive shaft |
US4854325A (en) * | 1987-11-09 | 1989-08-08 | Stevens Robert C | Reciprocating guidewire method |
US4906236A (en) | 1988-08-29 | 1990-03-06 | Alberts David S | Self-sheathing hypodermic needle |
DE3830909A1 (en) | 1988-09-10 | 1990-03-22 | Astra Meditec Ab | Varicose tube |
GB8829182D0 (en) * | 1988-12-14 | 1989-01-25 | Univ Birmingham | Surgical instrument |
US5087244A (en) | 1989-01-31 | 1992-02-11 | C. R. Bard, Inc. | Catheter and method for locally applying medication to the wall of a blood vessel or other body lumen |
US5019083A (en) * | 1989-01-31 | 1991-05-28 | Advanced Osseous Technologies, Inc. | Implanting and removal of orthopedic prostheses |
US5087265A (en) | 1989-02-17 | 1992-02-11 | American Biomed, Inc. | Distal atherectomy catheter |
US5078723A (en) | 1989-05-08 | 1992-01-07 | Medtronic, Inc. | Atherectomy device |
US5022399A (en) | 1989-05-10 | 1991-06-11 | Biegeleisen Ken P | Venoscope |
ES2081372T3 (en) | 1989-06-28 | 1996-03-01 | David S Zimmon | STOPPING BALL DEVICES. |
DE69023652T2 (en) | 1989-08-18 | 1996-10-31 | Evi Corp | ATHEROTOMY CATHETER. |
FR2651682B1 (en) | 1989-09-13 | 1991-10-25 | Cadet Pierre | APPARATUS FOR THE DESTRUCTION OF VARICAS OF LOWER MEMBERS IN MAN. |
US5100425A (en) * | 1989-09-14 | 1992-03-31 | Medintec R&D Limited Partnership | Expandable transluminal atherectomy catheter system and method for the treatment of arterial stenoses |
US5026384A (en) | 1989-11-07 | 1991-06-25 | Interventional Technologies, Inc. | Atherectomy systems and methods |
US5074871A (en) | 1989-12-07 | 1991-12-24 | Evi Corporation | Catheter atherotome |
WO1991019529A1 (en) | 1990-06-15 | 1991-12-26 | Cortrak Medical, Inc. | Drug delivery apparatus and method |
US5135517A (en) | 1990-07-19 | 1992-08-04 | Catheter Research, Inc. | Expandable tube-positioning apparatus |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
US5176646A (en) * | 1991-02-19 | 1993-01-05 | Takayuki Kuroda | Motorized syringe pump |
DE69119578T2 (en) | 1991-02-28 | 1996-12-19 | Pierre Cadet | Device for destroying varicose veins |
US6733473B1 (en) | 1991-04-05 | 2004-05-11 | Boston Scientific Corporation | Adjustably stiffenable convertible catheter assembly |
WO1993019679A1 (en) | 1992-04-07 | 1993-10-14 | The Johns Hopkins University | A percutaneous mechanical fragmentation catheter system |
IL101720A (en) * | 1992-04-29 | 1998-09-24 | Mali Tech Ltd | Needle for syringe or the like |
US5361768A (en) * | 1992-06-30 | 1994-11-08 | Cardiovascular Imaging Systems, Inc. | Automated longitudinal position translator for ultrasonic imaging probes, and methods of using same |
US5356418A (en) | 1992-10-28 | 1994-10-18 | Shturman Cardiology Systems, Inc. | Apparatus and method for rotational atherectomy |
US5643297A (en) | 1992-11-09 | 1997-07-01 | Endovascular Instruments, Inc. | Intra-artery obstruction clearing apparatus and methods |
CN2148536Y (en) | 1993-02-19 | 1993-12-08 | 董国祥 | Tube for extracting embolus from venous |
JPH08512225A (en) * | 1993-07-03 | 1996-12-24 | メディカル・ミラクルズ・カンパニー・リミテッド | Angioplasty catheter with guidewire |
US5370653A (en) | 1993-07-22 | 1994-12-06 | Micro Therapeutics, Inc. | Thrombectomy method and apparatus |
US5449351A (en) * | 1993-09-09 | 1995-09-12 | Zohmann; Walter A. | Atraumatic needle for lumbar puncture |
US6673025B1 (en) | 1993-12-01 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Polymer coated guidewire |
US5415636A (en) | 1994-04-13 | 1995-05-16 | Schneider (Usa) Inc | Dilation-drug delivery catheter |
US5836905A (en) | 1994-06-20 | 1998-11-17 | Lemelson; Jerome H. | Apparatus and methods for gene therapy |
US5891108A (en) | 1994-09-12 | 1999-04-06 | Cordis Corporation | Drug delivery stent |
US5549601A (en) * | 1994-10-11 | 1996-08-27 | Devices For Vascular Intervention, Inc. | Delivery of intracorporeal probes |
US5611357A (en) | 1995-02-09 | 1997-03-18 | Suval; William D. | Method and apparatus for treating varicose veins |
US5624452A (en) | 1995-04-07 | 1997-04-29 | Ethicon Endo-Surgery, Inc. | Hemostatic surgical cutting or stapling instrument |
US5749882A (en) | 1995-10-18 | 1998-05-12 | Applied Medical Resources Corporation | Apparatus for disrupting vein valves |
US5707355A (en) * | 1995-11-15 | 1998-01-13 | Zimmon Science Corporation | Apparatus and method for the treatment of esophageal varices and mucosal neoplasms |
US5675228A (en) | 1995-12-18 | 1997-10-07 | General Electric Company | Methods and apparatus for controlling energization of a motor |
CN1182885C (en) * | 1996-02-27 | 2005-01-05 | 英杰克蒂姆梅德公司 | Needle tip guard for hypodermic needle |
IE80772B1 (en) * | 1996-06-10 | 1999-02-10 | Elan Corp Plc | Delivery needle |
WO1997047342A2 (en) * | 1996-06-10 | 1997-12-18 | Elan Corporation Plc. | Needle for subcutaneous delivery of fluids |
US5976164A (en) | 1996-09-13 | 1999-11-02 | Eclipse Surgical Technologies, Inc. | Method and apparatus for myocardial revascularization and/or biopsy of the heart |
US6193735B1 (en) * | 1996-09-16 | 2001-02-27 | Robert C. Stevens | Combined rotary and axial reciprocating guide wire |
US5957941A (en) | 1996-09-27 | 1999-09-28 | Boston Scientific Corporation | Catheter system and drive assembly thereof |
US5851208A (en) * | 1996-10-15 | 1998-12-22 | Linvatec Corporation | Rotatable surgical burr |
US6311692B1 (en) | 1996-10-22 | 2001-11-06 | Epicor, Inc. | Apparatus and method for diagnosis and therapy of electrophysiological disease |
US6290675B1 (en) | 1997-01-09 | 2001-09-18 | Endosonics Corporation | Device for withdrawing a catheter |
US6129734A (en) | 1997-01-21 | 2000-10-10 | Shturman Cardiology Systems, Inc. | Rotational atherectomy device with radially expandable prime mover coupling |
US5911700A (en) | 1997-03-11 | 1999-06-15 | Microaire Surgical Instruments | Power assisted liposuction and lipoinjection equipment |
US5882329A (en) | 1997-02-12 | 1999-03-16 | Prolifix Medical, Inc. | Apparatus and method for removing stenotic material from stents |
US6015420A (en) * | 1997-03-06 | 2000-01-18 | Scimed Life Systems, Inc. | Atherectomy device for reducing damage to vessels and/or in-vivo stents |
US5843103A (en) * | 1997-03-06 | 1998-12-01 | Scimed Life Systems, Inc. | Shaped wire rotational atherectomy device |
US5908395A (en) * | 1997-03-17 | 1999-06-01 | Advanced Cardiovascular Systems, Inc. | Vibrating guidewire |
ES2224418T3 (en) | 1997-07-24 | 2005-03-01 | Rex Medical, L.P. | ROTATING THROMBECTOMY APPARATUS WITH STATIONARY WAVE. |
US6090118A (en) | 1998-07-23 | 2000-07-18 | Mcguckin, Jr.; James F. | Rotational thrombectomy apparatus and method with standing wave |
US7037316B2 (en) | 1997-07-24 | 2006-05-02 | Mcguckin Jr James F | Rotational thrombectomy device |
US5893858A (en) | 1997-10-06 | 1999-04-13 | Smith & Nephew, Inc. | Method for removing veins |
US6024749A (en) | 1997-10-27 | 2000-02-15 | Shturman Cardiology Systems, Inc. | Rotational atherectomy device with improved exchangeable drive shaft cartridge |
US6258087B1 (en) | 1998-02-19 | 2001-07-10 | Curon Medical, Inc. | Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
US6824550B1 (en) | 2000-04-06 | 2004-11-30 | Norbon Medical, Inc. | Guidewire for crossing occlusions or stenosis |
US6159196A (en) | 1998-03-09 | 2000-12-12 | Ruiz; Carlos | Methods and apparatus for transvascular muscular revascularization and drug delivery |
US6482217B1 (en) | 1998-04-10 | 2002-11-19 | Endicor Medical, Inc. | Neuro thrombectomy catheter |
US6001112A (en) * | 1998-04-10 | 1999-12-14 | Endicor Medical, Inc. | Rotational atherectomy device |
US6231518B1 (en) | 1998-05-26 | 2001-05-15 | Comedicus Incorporated | Intrapericardial electrophysiological procedures |
US6273882B1 (en) | 1998-06-18 | 2001-08-14 | Scimed Life Systems | Snap handle assembly for an endoscopic instrument |
US6369039B1 (en) | 1998-06-30 | 2002-04-09 | Scimed Life Sytems, Inc. | High efficiency local drug delivery |
US6504149B2 (en) * | 1998-08-05 | 2003-01-07 | National Research Council Canada | Apparatus and method for desolvating and focussing ions for introduction into a mass spectrometer |
US6319227B1 (en) | 1998-08-05 | 2001-11-20 | Scimed Life Systems, Inc. | Automatic/manual longitudinal position translator and rotary drive system for catheters |
US6171234B1 (en) | 1998-09-25 | 2001-01-09 | Scimed Life Systems, Inc. | Imaging gore loading tool |
WO2000018448A2 (en) * | 1998-09-30 | 2000-04-06 | A-Med Systems, Inc. | Method and apparatus for preventing air embolisms |
US6048332A (en) | 1998-10-09 | 2000-04-11 | Ave Connaught | Dimpled porous infusion balloon |
US6238335B1 (en) | 1998-12-11 | 2001-05-29 | Enteric Medical Technologies, Inc. | Method for treating gastroesophageal reflux disease and apparatus for use therewith |
US6066153A (en) * | 1999-03-31 | 2000-05-23 | Lev; Avigdor | Device and method for resecting body tissues |
US6350271B1 (en) | 1999-05-17 | 2002-02-26 | Micrus Corporation | Clot retrieval device |
DE60020566T2 (en) * | 1999-07-30 | 2006-05-04 | Boston Scientific Ltd., St. Michael | CATHETER WITH DRIVE AND CLUTCH FOR TURNING AND LENGTH SHIFTING |
US6709427B1 (en) * | 1999-08-05 | 2004-03-23 | Kensey Nash Corporation | Systems and methods for delivering agents into targeted tissue of a living being |
US6520928B1 (en) * | 1999-08-19 | 2003-02-18 | Alceu Meibach Rosa Junior | Medical liquid injection system and method |
US6575932B1 (en) * | 1999-12-02 | 2003-06-10 | Ottawa Heart Institute | Adjustable multi-balloon local delivery device |
US6613026B1 (en) * | 1999-12-08 | 2003-09-02 | Scimed Life Systems, Inc. | Lateral needle-less injection apparatus and method |
US6547776B1 (en) * | 2000-01-03 | 2003-04-15 | Curon Medical, Inc. | Systems and methods for treating tissue in the crura |
US6663613B1 (en) | 2000-01-25 | 2003-12-16 | Bacchus Vascular, Inc. | System and methods for clot dissolution |
US6572630B1 (en) * | 2000-01-31 | 2003-06-03 | Rex Medical, L.P | Atherectomy device |
US6402745B1 (en) | 2000-02-23 | 2002-06-11 | Peter J. Wilk | Intravenous whip electrode for vein ablation |
US7344546B2 (en) * | 2000-04-05 | 2008-03-18 | Pathway Medical Technologies | Intralumenal material removal using a cutting device for differential cutting |
EP1278467A2 (en) | 2000-04-07 | 2003-01-29 | Bacchus Vascular Inc. | Methods and device for percutaneous remote endarterectomy |
US6517528B1 (en) | 2000-04-13 | 2003-02-11 | Scimed Life Systems, Inc. | Magnetic catheter drive shaft clutch |
US6645221B1 (en) | 2000-05-30 | 2003-11-11 | Zuli, Holdings Ltd. | Active arterial embolization filter |
USD450843S1 (en) | 2000-05-30 | 2001-11-20 | Boston Scientific Corporation | Thrombectomy handpiece |
US7285126B2 (en) | 2000-06-29 | 2007-10-23 | Concentric Medical, Inc. | Systems, methods and devices for removing obstructions from a blood vessel |
US20030120256A1 (en) | 2001-07-03 | 2003-06-26 | Syntheon, Llc | Methods and apparatus for sclerosing the wall of a varicose vein |
US7077836B2 (en) | 2000-07-21 | 2006-07-18 | Vein Rx, Inc. | Methods and apparatus for sclerosing the wall of a varicose vein |
US6544221B1 (en) | 2000-08-30 | 2003-04-08 | Advanced Cardiovascular Systems, Inc. | Balloon designs for drug delivery |
US6679886B2 (en) | 2000-09-01 | 2004-01-20 | Synthes (Usa) | Tools and methods for creating cavities in bone |
EP1399213A4 (en) | 2000-10-11 | 2008-03-19 | Micro Therapeutics Inc | Methods for treating aneurysms |
DE10059742A1 (en) | 2000-12-01 | 2002-06-13 | Angiolas Medical Gmbh | System for treating vascular adhesions |
GB2369996B (en) * | 2000-12-18 | 2004-06-23 | S T D Pharmaceutical Products | Method and apparatus for producing an injectable foam |
US6623452B2 (en) | 2000-12-19 | 2003-09-23 | Scimed Life Systems, Inc. | Drug delivery catheter having a highly compliant balloon with infusion holes |
US6969373B2 (en) * | 2001-04-13 | 2005-11-29 | Tricardia, Llc | Syringe system |
US6500186B2 (en) * | 2001-04-17 | 2002-12-31 | Scimed Life Systems, Inc. | In-stent ablative tool |
US20030004568A1 (en) | 2001-05-04 | 2003-01-02 | Concentric Medical | Coated combination vaso-occlusive device |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US6599307B1 (en) * | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US6726674B2 (en) | 2001-09-04 | 2004-04-27 | Jomed Gmbh | Methods for minimally invasive, localized delivery of sclerotherapeutic agents |
US6852118B2 (en) | 2001-10-19 | 2005-02-08 | Shturman Cardiology Systems, Inc. | Self-indexing coupling for rotational angioplasty device |
US9440046B2 (en) * | 2002-04-04 | 2016-09-13 | Angiodynamics, Inc. | Venous insufficiency treatment method |
CA2484865A1 (en) | 2002-05-17 | 2003-11-27 | Dvl Acquisition Sub, Inc. | Surgical suturing instrument and method of use |
US7811260B2 (en) * | 2002-05-31 | 2010-10-12 | Vidacare Corporation | Apparatus and method to inject fluids into bone marrow and other target sites |
EP3292821A1 (en) * | 2002-05-31 | 2018-03-14 | Vidacare LLC | Apparatus and method to access bone marrow |
US7458967B2 (en) * | 2003-10-31 | 2008-12-02 | Angiodynamics, Inc. | Endovascular treatment apparatus and method |
US7644715B2 (en) | 2002-10-31 | 2010-01-12 | Cooltouch, Incorporated | Restless leg syndrome treatment |
EP1442720A1 (en) * | 2003-01-31 | 2004-08-04 | Tre Esse Progettazione Biomedica S.r.l | Apparatus for the maneuvering of flexible catheters in the human cardiovascular system |
US7211073B2 (en) | 2003-03-18 | 2007-05-01 | Catharos Medical Systems Inc. | Methods and devices for retrieval of a medical agent from a physiological efferent fluid collection site |
US20040199151A1 (en) * | 2003-04-03 | 2004-10-07 | Ceramoptec Industries, Inc. | Power regulated medical underskin irradiation treament system |
US20040236313A1 (en) * | 2003-05-21 | 2004-11-25 | Klein Jeffrey A. | Infiltration cannula |
EP1689335A1 (en) * | 2003-09-05 | 2006-08-16 | Sightrate B.V. | Device for separation of corneal epithelium |
US20050085836A1 (en) | 2003-09-12 | 2005-04-21 | Jean Raymond | Methods and devices for endothelial denudation to prevent recanalization after embolization |
GB0327957D0 (en) * | 2003-12-03 | 2004-01-07 | Btg Int Ltd | Apparatus for delivering foam |
US7046891B2 (en) | 2004-07-13 | 2006-05-16 | Corning Incorporated | Low cutoff large effective area optical fiber |
US8388671B2 (en) | 2004-07-15 | 2013-03-05 | Medtronic Vascular, Inc. | Methods for treatment of aneurysmal tissue |
US7402320B2 (en) | 2004-08-31 | 2008-07-22 | Vnus Medical Technologies, Inc. | Apparatus, material compositions, and methods for permanent occlusion of a hollow anatomical structure |
US7819887B2 (en) | 2004-11-17 | 2010-10-26 | Rex Medical, L.P. | Rotational thrombectomy wire |
US20060224110A1 (en) * | 2005-03-17 | 2006-10-05 | Scott Michael J | Methods for minimally invasive vascular access |
DE102005017546A1 (en) | 2005-04-16 | 2006-10-19 | Impella Cardiosystems Gmbh | Method for controlling a blood pump |
US7909836B2 (en) * | 2005-05-20 | 2011-03-22 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
US9162037B2 (en) * | 2005-07-06 | 2015-10-20 | Vascular Pathways, Inc. | Intravenous catheter insertion device and method of use |
EP1907041B1 (en) * | 2005-07-11 | 2019-02-20 | Catheter Precision, Inc. | Remotely controlled catheter insertion system |
EP2363070A1 (en) * | 2005-07-25 | 2011-09-07 | Hakko Co., Ltd. | Ultrasonic puncture needle |
EP1962924A2 (en) * | 2005-11-10 | 2008-09-03 | Mayo Foundation For Medical Education And Research | Vein closure and injection kits and methods |
US20080243068A1 (en) | 2005-12-29 | 2008-10-02 | Kamal Ramzipoor | Methods and apparatus for treatment of venous insufficiency |
US20080275432A1 (en) | 2006-05-11 | 2008-11-06 | Ceramoptec Industries, Inc. | Photodynamic foam composition and sclerosis treatment |
CN102327139A (en) | 2006-06-30 | 2012-01-25 | 阿瑟罗迈德公司 | Atherectomy device |
WO2008033983A1 (en) | 2006-09-13 | 2008-03-20 | Vascular Insights Llc | Vascular treatment device |
US20080097224A1 (en) * | 2006-10-20 | 2008-04-24 | Infraredx, Inc. | Manual and Motor Driven Optical Pullback and Rotation System and Method |
US20080172012A1 (en) * | 2006-10-31 | 2008-07-17 | Hiniduma-Lokuge Prasanga D | Injection needle having lateral delivery ports and method for the manufacture thereof |
US20080300571A1 (en) * | 2007-05-30 | 2008-12-04 | Lepivert Patrick | Process and device for selectively treating interstitial tissue |
US20090018486A1 (en) * | 2007-07-13 | 2009-01-15 | Menachem Goren | Diagnosis and treatment of vericocele and prostate disorders |
US10159472B2 (en) | 2008-03-02 | 2018-12-25 | V.V.T. Med Ltd. | Method and device for vein ablation |
US8062316B2 (en) | 2008-04-23 | 2011-11-22 | Avinger, Inc. | Catheter system and method for boring through blocked vascular passages |
WO2009141591A1 (en) | 2008-05-19 | 2009-11-26 | Jean-Pierre Lilley | Varicose vein treatment |
US8052645B2 (en) * | 2008-07-23 | 2011-11-08 | Avant Medical Corp. | System and method for an injection using a syringe needle |
US20100069760A1 (en) * | 2008-09-17 | 2010-03-18 | Cornova, Inc. | Methods and apparatus for analyzing and locally treating a body lumen |
JP5818357B2 (en) | 2009-02-10 | 2015-11-18 | ヴェサテック エルエルシー | Method and apparatus for operating a surgical guidewire |
EP2398402B1 (en) | 2009-02-20 | 2016-04-20 | Covidien LP | Devices for venous occlusion for the treatment of venous insufficiency |
GB0905748D0 (en) * | 2009-04-03 | 2009-05-20 | Shturman Leonid | Rotational atherectomy device with eccentric abrasive element and method of use |
WO2010124109A1 (en) * | 2009-04-22 | 2010-10-28 | Nuvue Therapeutics, Inc. | Fluid flowing device and method for tissue diagnosis or therapy |
US20110015484A1 (en) * | 2009-07-16 | 2011-01-20 | Alvarez Jeffrey B | Endoscopic robotic catheter system |
US20120265168A1 (en) * | 2009-08-12 | 2012-10-18 | Horowitz John D | Tumescent anesthesia delivery in connection with endovenous vein therapy |
US9585667B2 (en) | 2010-11-15 | 2017-03-07 | Vascular Insights Llc | Sclerotherapy catheter with lumen having wire rotated by motor and simultaneous withdrawal from vein |
US8690833B2 (en) * | 2011-01-31 | 2014-04-08 | Vascular Pathways, Inc. | Intravenous catheter and insertion device with reduced blood spatter |
DK2744424T3 (en) * | 2011-08-17 | 2018-01-22 | Samuel Shiber | Adaptively rotating catheter to open clogged vessels in the body |
-
2011
- 2011-07-29 US US13/194,253 patent/US9585667B2/en active Active
- 2011-11-14 US US13/295,495 patent/US9375216B2/en active Active
- 2011-11-14 US US13/295,518 patent/US8696645B2/en active Active
- 2011-11-15 AU AU2011328998A patent/AU2011328998A1/en not_active Abandoned
- 2011-11-15 CA CA2817545A patent/CA2817545C/en active Active
- 2011-11-15 JP JP2013539004A patent/JP6068355B2/en active Active
- 2011-11-15 EP EP18154183.0A patent/EP3378509B1/en active Active
- 2011-11-15 EP EP11841604.9A patent/EP2640442B1/en active Active
- 2011-11-15 JP JP2013539005A patent/JP2014500761A/en active Pending
- 2011-11-15 WO PCT/US2011/060855 patent/WO2012068162A2/en active Application Filing
- 2011-11-15 CA CA2817586A patent/CA2817586C/en not_active Expired - Fee Related
- 2011-11-15 EP EP11841343.4A patent/EP2640284B1/en active Active
- 2011-11-15 JP JP2013539006A patent/JP6035244B2/en active Active
- 2011-11-15 AU AU2011328997A patent/AU2011328997A1/en not_active Abandoned
- 2011-11-15 WO PCT/US2011/060859 patent/WO2012068165A2/en active Application Filing
- 2011-11-15 EP EP21160558.9A patent/EP3881783A1/en active Pending
- 2011-11-15 WO PCT/US2011/060860 patent/WO2012068166A2/en active Application Filing
- 2011-11-15 AU AU2011328994A patent/AU2011328994B2/en not_active Ceased
- 2011-11-15 EP EP11841745.0A patent/EP2640443A4/en not_active Withdrawn
- 2011-11-15 CA CA2817588A patent/CA2817588A1/en not_active Abandoned
-
2014
- 2014-03-18 US US14/218,527 patent/US11241250B2/en active Active
-
2015
- 2015-10-07 AU AU2015238815A patent/AU2015238815A1/en not_active Abandoned
- 2015-10-09 AU AU2015238901A patent/AU2015238901B2/en not_active Ceased
-
2016
- 2016-02-18 JP JP2016028487A patent/JP6262782B2/en active Active
- 2016-06-27 US US15/194,083 patent/US20160302822A1/en not_active Abandoned
-
2017
- 2017-08-24 JP JP2017161223A patent/JP6546631B2/en active Active
- 2017-11-30 AU AU2017268602A patent/AU2017268602B2/en active Active
-
2018
- 2018-06-15 AU AU2018204304A patent/AU2018204304B2/en not_active Ceased
- 2018-12-25 JP JP2018240455A patent/JP6626186B2/en active Active
-
2019
- 2019-12-30 US US16/730,824 patent/US20200129180A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876109A (en) * | 1987-04-13 | 1989-10-24 | Cardiac Pacemakers, Inc. | Soluble covering for cardiac pacing electrode |
US6482215B1 (en) * | 1999-02-02 | 2002-11-19 | Samuel Shiber | Adjustable vessel cleaner and method |
US20040147934A1 (en) * | 2002-10-18 | 2004-07-29 | Kiester P. Douglas | Oscillating, steerable, surgical burring tool and method of using the same |
US20050055040A1 (en) * | 2003-05-21 | 2005-03-10 | Tal Michael G. | Vascular ablation apparatus and method |
US20070239140A1 (en) * | 2006-03-22 | 2007-10-11 | Revascular Therapeutics Inc. | Controller system for crossing vascular occlusions |
US20080140101A1 (en) * | 2006-12-07 | 2008-06-12 | Revascular Therapeutic, Inc. | Apparatus for crossing occlusions or stenoses |
US20100125276A1 (en) * | 2008-11-14 | 2010-05-20 | Revascular Therapeutics, Inc. | Method and system for reversibly controlled drilling of luminal occlusions |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020077280A1 (en) * | 2018-10-12 | 2020-04-16 | Merit Medical Systems, Inc. | Vascular treatment apparatus with remote operating module |
WO2020077277A1 (en) * | 2018-10-12 | 2020-04-16 | Merit Medical Systems, Inc. | Vascular treatment apparatus with auto injection device and related methods |
IT201900001223A1 (en) | 2019-01-28 | 2020-07-28 | I Vasc Srl | Catheter handpiece, catheter and method |
US11696793B2 (en) | 2021-03-19 | 2023-07-11 | Crossfire Medical Inc | Vascular ablation |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20200129180A1 (en) | Direction reversing vascular treatment device | |
AU2017204839B2 (en) | Direction reversing vascular treatment device | |
EP1811908B1 (en) | Rotational thrombectomy wire | |
EP3164088B1 (en) | Improved atherectomy device | |
WO2009134346A3 (en) | Methods and apparatus for crossing occlusions in blood vessels | |
CN115227337B (en) | Vascular opening device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: VASCULAR INSIGHTS, LLC, MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAL, MICHAEL G.;MARANO, JOHN P.;SIGNING DATES FROM 20120201 TO 20120202;REEL/FRAME:047710/0870 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: MERIT MEDICAL SYSTEMS,INC., UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VASCULAR INSIGHTS, LLC;REEL/FRAME:050112/0151 Effective date: 20181214 |
|
AS | Assignment |
Owner name: MERIT MEDICAL SYSTEMS, INC., UTAH Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VASCULAR INSIGHTS, LLC;REEL/FRAME:048832/0232 Effective date: 20181214 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT, NORTH CAROLINA Free format text: SECURITY INTEREST;ASSIGNOR:MERIT MEDICAL SYSTEMS, INC.;REEL/FRAME:054899/0569 Effective date: 20201218 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |